Rewiring the Brain: Applying Spatial Omics to Neural Plasticity and Neurodegenerative Diseases

Q4 Biochemistry, Genetics and Molecular Biology

Genetic Engineering & Biotechnology News Pub Date : 2023-11-01 DOI:10.1089/gen.43.11.12

引用次数: 0

Abstract

Genetic Engineering & Biotechnology NewsVol. 43, No. 11 Sponsored ContentRewiring the Brain: Applying Spatial Omics to Neural Plasticity and Neurodegenerative DiseasesSpatial omics allows visualization of gene and protein expression, providing crucial information about the location and interactions of specific types of brain cellsPublished Online:9 Nov 2023https://doi.org/10.1089/gen.43.11.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 11Nov 2023 Information© 2023 by GEN PublishingTo cite this article:Rewiring the Brain: Applying Spatial Omics to Neural Plasticity and Neurodegenerative Diseases.Genetic Engineering & Biotechnology News.Nov 2023.33-33.http://doi.org/10.1089/gen.43.11.12Published in Volume: 43 Issue 11: November 9, 2023PDF download

查看原文本刊更多论文

重新连接大脑:将空间组学应用于神经可塑性和神经退行性疾病

基因工程与生物技术新闻卷。43、第11位赞助内容将空间组学应用于神经可塑性和神经退行性疾病空间组学允许基因和蛋白质表达的可视化，提供关于特定类型脑细胞的位置和相互作用的重要信息发表在线:2023年11月9日https://doi.org/10.1089/gen.43.11.12AboutSectionsView文章查看全文pdf /EPUB权限和CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites返回出版物ShareShare onFacebookTwitterLinked InRedditEmail查看文章figuresreferencesrelateddetails第43期2023年11月信息©2023 by GEN publishing引用这篇文章:Rewiring the脑:应用空间组学研究神经可塑性和神经退行性疾病。基因工程与生物技术新闻。2023.11月33-33.http://doi.org/10.1089/gen.43.11.12Published in Volume: 43 Issue 11: 11/11/2023pdf下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.